FDA panel votes to approve diabetes drug
from The New York Times
A federal advisory panel voted to approve a diabetes drug that could be the first in a new class of drugs in the United States to treat the disease, although several members raised concerns about potential cardiovascular risks and its use in people whose kidneys are impaired.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063